---
$id: https://graph.org.ai/products/commodity/51281601
$type: Product
source: UNSPSC
code: "51281601"
title: "Bluensomycin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bluensomycin

**UNSPSC Code**: 51281601
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C21H39N5O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LWV7PWE57U, chemically known as d-scyllo-inositol, o-2-deoxy-2-(methylamino)-alpha-l-glucopyranosyl-(1=>2)-o-5-deoxy-3-c-(hydroxymethyl)-alpha-l-lyxofuranosyl-(1=>2)-1-((aminoiminomethyl)amino)-1-deoxy-, 5-carbamate but generally known as bluensomycin, which bears US NIH Compound Identifier 65603. Bluensomycin most often comes in base and sulfate forms. The term BLUENSOMYCIN is an International Non-Proprietary Name. BLUENSOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bluensomycin under HS 29412080 and SITC 54132. As of Q4 2014, BLUENSOMYCIN remains the US FDA Preferred Term for this commodity. Bluensomycin bears US NLM identifiers UMLS ID C0053859 and NCI Concept Code C90636. SMILES: CC1C(C(C(O1)OC2C(C(C(C(C2O)O)OC(=O)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(CO)O.

